Furthermore, Stx caused downregulation of the complement inhibitor CD59 on tubular epithelial and glomerular endothelial cells [21] and from a clinical perspective, induced complement protein levels in patients with STEC-HUS at the time of hospital admission have been measured [22,23]. This evidence concerns the gene CD59 and hemolytic-uremic syndrome.